Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Recruiting

Phase 2

Ceralasertib & Olaparib, DurvalumabCeralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Sponsor:

Rahul Aggarwal

Code:

NCT03682289

Conditions

Clear Cell Renal Cell Carcinoma

Locally Advanced Pancreatic Cancer

Locally Advanced Malignant Solid Neoplasm

Metastatic Malignant Solid Neoplasm

Metastatic Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ceralasertib

Olaparib

Durvalumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Rahul Aggarwal on 2025-05-01.